mtRTK inhibitor WM-S1-030

{
  "id": "MLC-T-ONC-015326",
  "term": "mtRTK inhibitor WM-S1-030",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable inhibitor of mutant receptor tyrosine kinase (mtRTK; pTyr-mtRTK), with potential antineoplastic activity. Upon oral administration, mtRTK inhibitor WM-S1-030 targets and binds to mtRTK, thereby inhibiting mtRTK-mediated signaling pathways. This inhibits proliferation of tumor cells expressing mtRTK.",
  "synonyms": [
    "mutant receptor tyrosine kinase inhibitor WM-S1-030"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mtrtk-inhibitor-wm-s1-030/"
}